KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Treasury Shares (2017 - 2025)

NovoCure (NVCR) has disclosed Treasury Shares for 9 consecutive years, with $13.1 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 8.85% to $13.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.1 million through Dec 2025, up 8.85% year-over-year, with the annual reading at $13.1 million for FY2025, 8.85% up from the prior year.
  • Treasury Shares hit $13.1 million in Q4 2025 for NovoCure, down from $13.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $13.9 million in Q1 2025 to a low of $4.5 million in Q3 2021.
  • Historically, Treasury Shares has averaged $8.4 million across 5 years, with a median of $5.8 million in 2023.
  • Biggest five-year swings in Treasury Shares: decreased 2.8% in 2021 and later skyrocketed 142.87% in 2024.
  • Year by year, Treasury Shares stood at $4.5 million in 2021, then increased by 20.59% to $5.4 million in 2022, then increased by 8.1% to $5.8 million in 2023, then soared by 107.58% to $12.1 million in 2024, then grew by 8.85% to $13.1 million in 2025.
  • Business Quant data shows Treasury Shares for NVCR at $13.1 million in Q4 2025, $13.6 million in Q3 2025, and $13.7 million in Q2 2025.